Drugs & Diseases

Recent Drug Updates

  • motixafortide (Aphexda) FDA approves CXCR4 antagonist for HSC mobilization in patients with multiple myeloma
  • dabrafenib (Tafinlar) Indication for BRAF V600E-positive solid tumors expanded to include children aged 1 year and older
  • trametinib (Mekinist) Indication expanded to children aged 1 year and older for BRAF V600E-positive solid tumors

Slideshow Collections